1. Are presynaptic GABA-Cρ2 receptors involved in anti-nociception?
- Author
-
Padmesh S. Rajput, Bhagavatula R. Sastry, Peter J. Soja, Ujendra Kumar, J. Hwang, and Ramakrishna Tadavarty
- Subjects
Male ,Agonist ,Pyridines ,medicine.drug_class ,Central nervous system ,Pain ,Receptors, Presynaptic ,Immunofluorescence ,medicine ,Animals ,GABA-A Receptor Agonists ,GABA-A Receptor Antagonists ,Rats, Wistar ,Isoguvacine ,Receptor ,medicine.diagnostic_test ,Chemistry ,General Neuroscience ,Receptors, GABA-A ,Spinal cord ,Receptor antagonist ,Phosphinic Acids ,medicine.anatomical_structure ,Nociception ,nervous system ,Crotonates ,Substantia Gelatinosa ,Isonicotinic Acids ,Neuroscience - Abstract
We investigated the anti-nociceptive effects of GABA-C receptors in the central nervous system. Intracisternal injection of CACA, a GABA-C receptor agonist or isoguvacine, a GABA-A receptor agonist, significantly increased the tail-withdrawal latency. TPMPA, a GABA-C receptor antagonist blocked the effects of CACA but not isoguvacine indicating that GABA-C receptors are involved in regulating pain. Further, double-labelled immunofluorescence studies revealed that GABA-Cρ2 receptors are expressed presynaptically in the spinal dorsal horn, especially, substantia gelatinosa, a region that has been previously implicated in analgesia by regulating nociceptive inflow. These data provide a provenance for future work looking at presynaptic spinal GABA-C receptors in the control of nociception.
- Published
- 2015
- Full Text
- View/download PDF